Actionable genotypes beyond the coding sequence and their association with lifespan in the UK Biobank.
Researchers found that rare genetic variants in gene promoters independently predict lifespan, suggesting doctors should screen beyond coding sequences when assessing inherited disease risk.
Using saturation mutagenesis combined with massively parallel reporter assays to functionally map every potential variant in core promoters of 81 ACMG secondary findings genes, the authors identified that functional promoter variants—though individually rare—contribute to excess mortality independently of coding actionable genotypes. This is the first large-scale demonstration that non-coding regulatory variants in ACMG genes predict lifespan, with significant implications for expanding secondary genomic findings lists beyond coding sequences in clinical genomics.
What the study was
- Study design
- prospective_cohort_large_scale_genomics
- Population
- UK Biobank participants (WGS subsample)
- Sample size
- 490086
- Category
- Genomics/Precision Medicine
- Maturity
- Validated
- Journal
- J Med Genet
Why it surfaced
UK Biobank N=490,086 with WGS is the largest-ever actionable genotype study; functional annotation via MPRA is methodologically novel; direct mortality association elevates clinical significance; reshapes precision medicine reporting standards.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.